FOXP2 Expression in Frontotemporal Lobar Degeneration-Tau

J Alzheimers Dis. 2016 Sep 6;54(2):471-5. doi: 10.3233/JAD-160274.

Abstract

FOXP2 is altered in a variety of language disorders. We found reduced mRNA and protein expression of FOXP2 in frontal cortex area 8 in Pick's disease, and frontotemporal lobar degeneration-tau linked to P301L mutation presenting with language impairment in comparison with age-matched controls and cases with parkinsonian variant progressive supranuclear palsy. Foxp2 mRNA and protein are also reduced with disease progression in the somatosensory cortex in transgenic mice bearing the P301S mutation in MAPT when compared with wild-type littermates. Our findings support the presence of FOXP2 expression abnormalities in sporadic and familial frontotemporal degeneration tauopathies.

Keywords: FOXP2; P301S transgenic mice; Pick’s disease; frontotemporal lobar degeneration; language; tauopathy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Forkhead Transcription Factors / biosynthesis*
  • Forkhead Transcription Factors / genetics
  • Frontal Lobe / metabolism
  • Frontal Lobe / pathology
  • Frontotemporal Dementia / genetics
  • Frontotemporal Dementia / metabolism*
  • Frontotemporal Dementia / pathology
  • Gene Expression
  • Humans
  • Male
  • Mice
  • Mice, Transgenic
  • tau Proteins / biosynthesis*
  • tau Proteins / genetics

Substances

  • FOXP2 protein, human
  • Forkhead Transcription Factors
  • MAPT protein, human
  • tau Proteins